Apotex announced a voluntary recall of 4 lots of Drospirenone and Ethinyl Estradiol Tablets 3mg/0.03mg due to the possibility of defective blisters with incorrect tablet arrangements and/or empty blister pockets.
Eli Lilly announced plans to launch an authorized generic version of Humalog (insulin lispro) 100 Units/mL at a 50% lower list price.
Eli Lilly announced plans to launch an authorized generic version of Humalog (insulin lispro) 100 Units/mL at a 50% lower list price.
Boehringer Ingelheim and Lilly announced that the CAROLINA trial met its primary endpoint, demonstrating no increased cardiovascular (CV) risk with linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, when compared with glimepiride, a sulfonylurea, in patients with type 2 diabetes and CV risk.
